Welcome to our dedicated page for FLOWCO HLDGS SEC filings (Ticker: FLOC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Oil wells don’t just pump; they whisper a stream of technical and environmental data that Flowco Holdings Inc must report. Those whispers become hundreds of pages of 10-Ks, 10-Qs, and 8-Ks packed with artificial-lift engineering specs, rental utilization rates, and methane-abatement metrics. If locating segment margins or spotting when executives file a Form 4 feels overwhelming, you’re not alone.
Stock Titan solves the problem in seconds. Our AI reads every new submission to EDGAR, surfaces plain-language answers, and links you straight to the original document. Need the latest Flowco Holdings Inc quarterly earnings report 10-Q filing? It’s summarized and compared quarter-over-quarter. Curious about Flowco Holdings Inc insider trading Form 4 transactions? AGÕæÈ˹ٷ½-time alerts show who bought or sold, with context. We even flag each Flowco Holdings Inc 8-K material events explained so you understand production outages or contract wins without decoding legal jargon.
Here’s how professionals use the page:
- Track Flowco Holdings Inc executive stock transactions Form 4 before new basin deployments.
- Review the Flowco Holdings Inc annual report 10-K simplified to see rental fleet utilization and compression sales trends.
- Compare methane-reduction spending across filings with �Flowco Holdings Inc SEC filings explained simply�.
- Dive into the Flowco Holdings Inc proxy statement executive compensation to understand incentive alignment.
Stop skimming PDFs. Start understanding Flowco Holdings Inc SEC documents with AI—live updates, comprehensive coverage, and actionable insights, all in one place with Flowco Holdings Inc earnings report filing analysis already done for you.
BK Technologies Corp. (BKTI) � Schedule 13G/A (Amendment 1)
The filing discloses that investor Mikhail Stiskin, through his wholly-owned entities Hilve Holdings Ltd. (Cyprus) and Valdor Global DMCC (UAE), now beneficially owns 253,164 BKTI common shares, or 6.9 % of the 3,673,594 shares outstanding as of 8 May 2025. Ownership is held entirely with sole voting and dispositive power; no shares are held jointly.
Breakdown: Hilve Holdings directly holds 220,833 shares (6.0 %); Valdor Global DMCC holds 32,331 shares (0.9 %). The positions exceed the 5 % threshold that triggers a passive Schedule 13G filing, indicating the shares were acquired without intent to influence control of the issuer. The date of the reportable event is 30 Jun 2025, and signatures are dated 5 Aug 2025.
No financial metrics, purchase prices, or transaction dates beyond the ownership snapshot are provided. The filing simply updates beneficial ownership and does not announce any corporate action, change-in-control effort, or strategic agreement.
Schedule 13G/A Amendment No. 1 � Analog Devices, Inc. (ADI)
On 31 Jul 2025 JPMorgan Chase & Co. disclosed beneficial ownership of 21,856,594 common shares of ADI, representing 4.4 % of the outstanding class. The bank holds sole voting power over 19,228,968 shares and shared voting power over 195,959 shares; it retains sole dispositive power over 21,703,933 shares and shared dispositive power over 134,392 shares.
Because its stake has fallen below the 5 % reporting threshold, Item 5 is checked, indicating JPMorgan is no longer a 5 % beneficial owner. The filing states the position is held in the ordinary course of business with no intent to influence control. A subsidiary list details the multiple global asset-management entities that collectively hold the shares.
While JPMorgan remains a sizeable holder, the reduced ownership may signal portfolio re-balancing and could modestly affect investor sentiment toward ADI’s share-holder base.
Celularity Inc. (symbol: CELUW) filed a new Form D reporting a completed Rule 506(b) private placement. The company sold $1.035 million of equity, warrants and the underlying securities to 14 investors, with the first sale on 22 Jul 2025. The entire authorized amount has been placed, leaving $0 remaining; the offering will not last beyond one year and is unrelated to any merger or acquisition. No broker-dealers were engaged, so no sales commissions or finder’s fees were paid. The minimum investment was listed as $0, and the company states that none of the proceeds will be paid to executive officers, directors or promoters named in the filing. Celularity, incorporated in Delaware and operating from Florham Park, NJ, classified itself under the Biotechnology industry group but declined to disclose its revenue range.
Ardelyx (ARDX) has filed an 8-K detailing three material events.
Item 2.02 � Results of Operations: Q2-25 financial results were released separately as Exhibit 99.1; the filing itself contains no revenue, EPS or guidance figures.
Item 5.02 � Executive Transition: CFO/COO Justin Renz will leave the role on the earlier of 31 Dec 2025 or 30 days after a new CFO begins. Under an August 1, 2025 Transition Agreement he will (i) remain on current salary, benefits and 2025 bonus eligibility (individual component fixed at 100%) through the separation date and (ii) receive change-in-control severance and a 12-month post-separation option exercise window, subject to customary release and compliance conditions.
Item 5.03 � Governance Changes: The Board adopted Second Amended & Restated Bylaws effective August 1. Key revisions tighten shareholder proposal procedures (record-holder requirement, 67% solicitation threshold, nominee cap), update quorum language, drop physical shareholder-list production, introduce a forum-selection clause and make other technical edits.
No other business, transactions or financial statements were reported.
AngloGold Ashanti (AU) posted a transformational H1-25. Gold income surged 74 % to US$4.33 bn as managed sales rose 24 % to 1.40 Moz and the realised price climbed 41 % to US$3,090/oz, taking total revenue to US$4.41 bn (+73 %). Gross profit more than doubled to US$2.04 bn, driving profit before tax up 206 % to US$1.78 bn and attributable profit up 257 % to US$1.11 bn (219 US¢/sh).
Cost of sales grew 35 % to US$2.37 bn, largely from higher royalties and a US$224 m jump in amortisation (Sukari contribution). All-in sustaining cost for managed mines edged 1 % higher to US$1,676/oz; total cash cost was US$1,228/oz (+2 %). Net operating cash flow leapt 159 % to US$1.74 bn, comfortably covering 33 % higher capex of US$653 m. Liquidity is strong at ~US$3.4 bn; borrowings were broadly flat at US$2.30 bn, while cash rose 42 % to US$1.99 bn.
Operationally, Africa managed production jumped 48 % to 879 koz, aided by newly-acquired Sukari and strong Geita, Siguiri and Obuasi performance; Kibali JV output fell 13 %. Australia added 6 %, whereas the Americas slipped 4 %. Strategic actions include: agreed sale of Serra Grande (US$76 m), exit of G2 Goldfields stake (US$70 m gain), proposed US$111 m Augusta Gold acquisition to deepen Nevada portfolio, and a 20 % gold-offtake deal with the Bank of Tanzania. The board declared an interim dividend of US$406 m (80 US¢/sh). Safety improved with TRIFR down to 0.95 (-7 % YoY).
JPMorgan Chase & Co. filed Amendment No. 1 to its Schedule 13G reporting its beneficial ownership in Yum! Brands, Inc. (YUM) as of 30 June 2025. The bank and its subsidiaries disclose aggregate beneficial ownership of 18,165,911 common shares, representing 6.5 % of YUM’s outstanding stock. Within this total, JPMorgan has sole voting power over 16,397,437 shares and shared voting power over 157,631 shares; it holds sole dispositive power over 18,055,947 shares and shared dispositive power over 104,615 shares. The filer is organized in Delaware and certifies that the shares were acquired and are held in the ordinary course of business, without intent to influence control of the issuer. Subsidiaries listed as holding or managing the securities include J.P. Morgan Securities LLC, JPMorgan Chase Bank N.A., multiple international asset-management units, and others. The filing is made pursuant to Rule 13d-1(b) as JPMorgan qualifies as a parent holding company/control person. Signature was provided by Vice President Rachel Tsvaygoft on 24 July 2025.
BlackRock Portfolio Management LLC filed Amendment No. 1 to Schedule 13G for Fortrea Holdings Inc. (FTRE) covering holdings as of 30 Jun 2025. The firm reports beneficial ownership of 804,040 common shares, equal to 0.9 % of outstanding stock, placing the position well below the 5 % threshold that would trigger additional reporting requirements.
BlackRock has sole voting power over 714,353 shares and sole dispositive power over the full 804,040-share stake; it reports no shared voting or dispositive power. The filing states the shares were acquired and are held in the ordinary course of business, without intent to influence control. Because ownership is under 5 %, the filer confirms compliance with Item 5 and notes that no single client owns more than 5 % of FTRE. The document is certified by Managing Director Spencer Fleming on 15 Jul 2025.